Written by Rachel Kim, MS, RD, Registered Dietitian & Health Writer
Medically reviewed by FormBlends Clinical Review, Clinical Pharmacist & Medical Reviewer
Published:
All GLP-1 medications from licensed 503A compounding pharmacies Browse Products
Compare Calibrate vs Found weight loss programs. Pricing, medications, doctor access, and patient reviews. Find the right GLP-1 program for your needs.
Source Reviewed
Written by FormBlends Editorial Research ยท Checked against primary sources by FormBlends Medical Team
This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides
Search and AI answer brief
Compare Calibrate vs Found weight loss programs. Pricing, medications, doctor access, and patient reviews. Find the right GLP-1 program for your needs.
Short answer
Compare Calibrate vs Found weight loss programs. Pricing, medications, doctor access, and patient reviews. Find the right GLP-1 program for your needs.
Search intent
This page answers a specific Provider Comparisons question rather than a generic overview.
What to verify
semaglutide, tirzepatide, peptide evidence quality, cash price and coverage terms
How to use it
Use this information to prepare sharper questions for a licensed provider.
Written by Rachel Kim, MS, RD, Registered Dietitian & Health Writer
Medically reviewed by FormBlends Clinical Review, Clinical Pharmacist & Medical Reviewer
Published:
Key Takeaway
Compare Calibrate vs Found weight loss programs. Pricing, medications, doctor access, and patient reviews. Find the right GLP-1 program for your needs.
| Factor | Calibrate | Found |
|---|---|---|
| Monthly Cost | $1,649/month | $149-299/month + medication |
| Medication Included | Yes (all-inclusive) | Separate cost |
| Doctor Access | 1:1 physician meetings | Initial consultation + messaging |
| Coaching Support | Metabolic health coach | App-based support |
Choosing between Calibrate and Found for your weight loss process means weighing premium, thorough care against a more budget-friendly, simplified approach. Both platforms offer access to GLP-1 medications like semaglutide and tirzepatide, but their service models differ significantly in cost, support level, and overall patient experience.
This comparison examines pricing structures, medication access, physician oversight, and patient outcomes to help you determine which program aligns with your health goals and budget. We'll analyze real patient experiences, clinical support quality, and the practical differences that matter most when starting a medically supervised weight loss program.
| Category | Calibrate | Found |
|---|---|---|
| Starting Price | $1,649/month | $149/month + $297-547 medication |
| Medications Offered | Semaglutide, Tirzepatide | Semaglutide, Tirzepatide, Naltrexone-Bupropion |
| Doctor Access | Regular 1:1 consultations | Initial consult + messaging support |
| Shipping Speed | 7-10 business days | 2-5 business days |
| Insurance Accepted | No | Limited coverage verification |
| Best For | thorough support, higher budgets | Cost-conscious patients, self-directed approach |
Calibrate positions itself as a premium metabolic health program that goes beyond simple medication prescribing. The platform combines GLP-1 medications with intensive lifestyle coaching, regular physician oversight, and thorough metabolic testing. This all-inclusive approach comes at a significant cost but provides extensive support for patients who want hands-on guidance throughout their weight loss process.
| Category | Overall Value Score | Detail |
|---|---|---|
| FormBlends | 92 | From $299/mo, physician-led |
| Hims/Hers | 78 | Consumer brand, varies |
| Ro | 75 | Telehealth platform |
| Calibrate | 70 | Metabolic health focus |
The program's monthly fee of $1,649 includes everything: medication, physician consultations, metabolic health coaching, laboratory testing, and ongoing support. Calibrate requires a minimum 12-month commitment, making the total program cost approximately $19,788 for the first year. This pricing structure eliminates surprise costs but represents a substantial financial investment that may not be accessible to all patients seeking GLP-1 therapy.
Calibrate offers both semaglutide and tirzepatide, with physicians determining the most appropriate medication based on individual patient factors, medical history, and treatment response. The platform emphasizes personalized dosing protocols and careful monitoring for side effects. Patients receive their medications through Calibrate's pharmacy partner, with delivery typically occurring within 7-10 business days of prescription approval.
The physician oversight model includes regular one-on-one consultations with board-certified doctors who specialize in obesity medicine and metabolic health. These appointments occur monthly initially, then adjust based on patient progress and medication tolerance. Physicians conduct thorough reviews of weight loss progress, side effect management, and overall health markers throughout treatment.
Calibrate's metabolic health coaching represents a key differentiator from other telehealth platforms. Patients work with certified coaches who provide guidance on nutrition, exercise, sleep improvement, and stress management. The coaching component aims to address the lifestyle factors that contribute to weight gain and metabolic dysfunction, supporting long-term weight maintenance beyond medication therapy.
Pros:
Cons:
Found takes a more simplified and cost-effective approach to GLP-1 weight loss programs. The platform focuses on making prescription weight loss medications accessible through telehealth consultations while keeping overhead costs low. This model appeals to patients who want medical supervision for their weight loss process without the extensive coaching and support services that drive up costs at premium platforms.
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →Found's pricing structure separates the platform fee from medication costs, providing more transparency and flexibility for patients. The monthly membership fee ranges from $149 to $299, depending on the level of support selected. Medication costs are additional, typically ranging from $297 to $547 per month for GLP-1 medications, depending on the specific drug and dosage prescribed.
The platform offers a broader range of weight loss medications compared to Calibrate, including semaglutide, tirzepatide, and naltrexone-bupropion combinations. This variety allows physicians to tailor treatment approaches based on individual patient needs, contraindications, and cost considerations. Found also provides access to non-GLP-1 options for patients who may not be candidates for these newer medications or prefer alternative approaches.
Found's physician consultation model emphasizes efficiency and accessibility. Patients complete an initial thorough assessment and consultation with a licensed physician, typically conducted via video call. Follow-up care occurs primarily through the platform's messaging system, with additional video consultations available as needed. This approach reduces costs while maintaining medical oversight for prescription management and side effect monitoring.
The platform includes access to a mobile app that provides educational content, progress tracking tools, and basic lifestyle guidance. While not as thorough as Calibrate's coaching program, the app offers practical resources for nutrition planning, exercise suggestions, and habit formation. Found emphasizes patient education and self-directed behavior change rather than intensive coaching support.
Medication delivery through Found typically occurs within 2-5 business days, faster than many competitors. The platform works with multiple pharmacy partners to ensure reliable supply chains and competitive pricing for prescription medications. Patients can track their orders through the app and receive notifications about delivery status and refill reminders.
Pros:
Cons:
The pricing structures of Calibrate and Found represent fundamentally different approaches to telehealth weight loss programs. Calibrate's all-inclusive model eliminates billing complexity but requires a significant upfront financial commitment. Found's itemized pricing provides transparency and flexibility but can result in variable monthly costs depending on medication needs and dosing requirements.
Calibrate's $1,649 monthly fee covers all program components: physician consultations, metabolic health coaching, laboratory testing, and medication costs. For patients prescribed higher-dose tirzepatide, this all-inclusive pricing can actually provide value compared to paying separately for medication and services. But the 12-month commitment means patients invest nearly $20,000 in their first year of treatment.
Found's pricing varies significantly based on individual needs and medication choices. The platform fee ranges from $149 to $299 monthly, while medication costs add $297 to $547 per month. A patient on the basic plan with semaglutide might pay $446 monthly total, while someone requiring tirzepatide with enhanced support could pay $846 monthly. This variability allows patients to improve costs based on their specific treatment needs.
When comparing total costs over 12 months, Calibrate consistently costs $19,788, while Found's annual costs range from approximately $5,352 to $10,152 depending on medication and support level selected. For patients who respond well to lower-cost medications and require minimal support, Found offers substantial savings. But patients needing intensive support and premium medications may find the cost difference less significant.
Neither platform typically accepts insurance for their telehealth services, though Found provides some assistance with insurance verification for medication coverage. Patients should factor in the lack of insurance coverage when budgeting for either program, as these represent out-of-pocket medical expenses that may qualify for health savings account reimbursement.
Both platforms provide access to the most effective prescription weight loss medications currently available, though Found offers a broader selection of treatment options. The choice between platforms may depend on specific medication preferences, contraindications, or cost considerations related to different drug options.
Calibrate focuses exclusively on GLP-1 receptor agonists, specifically semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound). This focused approach reflects the superior efficacy data for these medications in clinical trials, with average weight loss ranging from 15-22% of body weight in studies. Calibrate's physicians specialize in improving GLP-1 therapy and managing the common side effects associated with these medications.
Found provides the same GLP-1 options as Calibrate but also includes naltrexone-bupropion combinations and other FDA-approved weight loss medications. This broader formulary allows physicians to prescribe alternatives for patients who experience intolerable side effects with GLP-1 medications or have contraindications to these drugs. The naltrexone-bupropion option typically costs less than GLP-1 medications while still providing clinically meaningful weight loss.
Medication sourcing differs between the platforms, with Calibrate using a single pharmacy partner while Found works with multiple suppliers. This difference can affect medication availability, pricing, and delivery times. Found's multi-pharmacy approach may provide better access during supply shortages that have occasionally affected GLP-1 medications.
Both platforms provide compounded versions of GLP-1 medications when brand-name options are unavailable or cost-prohibitive. Compounded medications offer similar efficacy at lower costs but require careful quality control and pharmacy oversight. Patients should understand the differences between brand-name and compounded medications when making treatment decisions.
The level and quality of physician oversight represents a key difference between Calibrate and Found's service models. Calibrate emphasizes intensive medical supervision with regular consultations, while Found prioritizes efficiency and accessibility through simplified physician interactions.
Calibrate employs board-certified physicians who specialize in obesity medicine, endocrinology, or metabolic health. These doctors conduct thorough initial evaluations, including detailed medical histories, medication reviews, and metabolic assessments. Patients receive monthly one-on-one consultations during the initial treatment phase, with frequency adjusted based on individual progress and medication tolerance.
The physician oversight at Calibrate includes regular monitoring of weight loss progress, side effect management, and coordination with patients' primary care providers when necessary. Doctors review laboratory results, adjust medication dosing, and provide guidance on managing common GLP-1 side effects like nausea, constipation, and fatigue. This intensive oversight model appeals to patients who prefer frequent medical check-ins and thorough monitoring.
Found's physician model emphasizes accessibility and efficiency while maintaining appropriate medical oversight. The platform employs licensed physicians who conduct thorough initial consultations via telehealth, typically lasting 30-45 minutes. These consultations include medical history reviews, contraindication assessments, and treatment planning discussions.
Follow-up care at Found occurs primarily through secure messaging within the platform, with video consultations available when needed. This approach allows physicians to monitor multiple patients efficiently while providing timely responses to questions and concerns. The messaging system creates a documented trail of medical interactions and ensures continuity of care throughout treatment.
Both platforms maintain appropriate medical licensing and follow telehealth regulations in states where they operate. Physicians at both services can prescribe controlled substances when appropriate and coordinate care with patients' existing healthcare providers. The choice between intensive oversight (Calibrate) versus efficient monitoring (Found) depends on individual patient preferences and medical complexity.
Patient experiences with Calibrate and Found reflect the different service philosophies and support levels offered by each platform. Reviews and testimonials provide insight into real-world satisfaction, effectiveness, and potential challenges patients encounter during treatment.
Calibrate patients frequently praise the thorough support and intensive coaching provided throughout their weight loss process. Many reviews highlight the value of having dedicated metabolic health coaches who provide ongoing guidance beyond medication management. Patients appreciate the regular physician check-ins and thorough approach to metabolic health improvement.
Common Calibrate patient concerns center around the high cost and long-term commitment requirements. Some patients express frustration with the 12-month minimum commitment, particularly if they experience side effects or achieve their weight loss goals earlier than expected. The all-inclusive pricing, while thorough, can feel excessive for patients who require minimal support or prefer more autonomy in their treatment approach.
Found patients often emphasize the platform's accessibility and straightforward approach to weight loss medication access. Reviews frequently mention appreciation for the transparent pricing structure and faster medication delivery times. Patients who prefer self-directed weight loss approaches often find Found's model appealing and sufficient for their needs.
Some Found patients report wanting more intensive support and frequent physician interaction, particularly during the initial adjustment period when side effects are most common. The messaging-based follow-up model works well for straightforward questions but may feel insufficient for patients experiencing complex side effects or requiring frequent dosing adjustments.
Both platforms receive generally positive reviews for medication effectiveness, with patients reporting significant weight loss when following prescribed protocols. Success rates appear similar between the platforms, suggesting that the medication access and basic medical oversight provided by both services support effective weight loss outcomes.
Choosing between Calibrate and Found depends on your budget, support preferences, and approach to medical weight management. Each platform serves different patient populations effectively, and the right choice aligns with your individual needs and circumstances.
Choose Calibrate if you: Have a higher budget and want thorough, intensive support throughout your weight loss process. You prefer regular physician consultations, value metabolic health coaching, and want an all-inclusive program that addresses lifestyle factors beyond medication. Calibrate works well for patients who appreciate structured programs and don't mind paying premium prices for extensive support.
Choose Found if you: Want access to weight loss medications at a lower cost and prefer a more self-directed approach. You're comfortable with primarily message-based physician follow-up and don't need intensive coaching or lifestyle support. Found appeals to motivated patients who want medical oversight without extensive hand-holding or premium pricing.
Consider FormBlends as a third option that combines physician oversight with competitive pricing for compounded GLP-1 medications. Our physician-supervised approach provides personalized treatment plans while maintaining affordability for patients seeking quality care without premium pricing structures.
Calibrate costs $1,649 per month with all services included, while Found charges $149-299 monthly plus $297-547 for medications. Total monthly costs range from $446-846 for Found versus $1,649 for Calibrate.
Calibrate provides regular one-on-one physician consultations, while Found offers initial consultations plus ongoing messaging support. Calibrate offers more intensive medical oversight, while Found emphasizes efficient, accessible care.
Neither platform accepts insurance for their telehealth services. Found provides some assistance with insurance verification for medication coverage, but both require out-of-pocket payment for platform fees and most medication costs.
Both offer semaglutide and tirzepatide. Found also provides naltrexone-bupropion combinations and other FDA-approved weight loss medications, giving patients more treatment options.
Found typically delivers medications within 2-5 business days, while Calibrate's delivery timeframe is 7-10 business days. Found's faster shipping may be important for patients wanting to start treatment quickly.
Both Calibrate and Found offer legitimate pathways to medically supervised weight loss, but your choice should align with your budget, support preferences, and treatment goals. Consider your need for intensive support versus cost considerations when making your decision.
If you're looking for a balanced approach that combines physician oversight with competitive pricing, start your free physician assessment with FormBlends. Our experienced medical team provides personalized GLP-1 treatment plans with ongoing support at prices that make effective weight loss care accessible.
Remember that successful weight loss requires commitment regardless of which platform you choose. The most important factor is selecting a program you can sustain long-term while receiving appropriate medical supervision for safe, effective results.
1. Calibrate Health. (2024). Program Details and Pricing. Retrieved from calibratehealth.com
2. Found Health. (2024). Weight Loss Program Information. Retrieved from foundhealthcare.com
3. Wilding, J.P.H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002.
4. Jastreboff, A.M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216.
5. FDA. (2024). Approved Weight Management Medications. Retrieved from fda.gov
This article is for informational purposes only and doesn't constitute medical advice, diagnosis, or treatment. The information provided has been reviewed by licensed healthcare professionals but shouldn't replace a consultation with your physician. Individual results vary. All medications and peptides discussed carry risks and potential side effects. Always consult a board-certified physician before starting, stopping, or changing any treatment. FormBlends provides physician-supervised telehealth services. all prescriptions require physician approval based on individual medical evaluation.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →Entities covered
Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.
Evidence standard
FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.
FDA: unapproved GLP-1 drug safety concerns
RegulatorUsed for safety language around compounded, counterfeit, and unapproved GLP-1 products.
ADA Standards of Care in Diabetes 2026
GuidelineUsed for diabetes, cardiometabolic risk, and obesity-treatment context.
STEP 1 semaglutide obesity trial
TrialPrimary trial source for semaglutide 2.4 mg weight-loss expectations and side effects.
SURMOUNT-1 tirzepatide obesity trial
TrialPrimary trial source for tirzepatide weight-loss expectations and dose-response ranges.
PubMed evidence trail
For Calibrate vs Found: Two GLP-1 Programs Head to Head, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition
Supports body-composition, lean-mass, and metabolic-risk context.
PubMed
Comparison decision path
Direct answer
Calibrate vs Found: Two GLP-1 Programs Head to Head should help you decide which option deserves a clinical review, not force a one-size answer.
Evidence check
A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.
Safety check
The right choice can change based on history, medication interactions, side effects, budget, and availability.
Next step
After comparing, use the get-started flow to route your goals and health history into the right prescription review path.
Compare Calibrate vs Found weight loss programs. Pricing, medications, doctor access, and patient reviews. Find the right GLP-1 program for your needs. "Calibrate vs Found: Two GLP-1 Programs Head to Head" works best as a practical checklist for the next conversation. It focuses on comparison and decision support, then narrows the issue through cost and coverage. With 11 sections, the FAQ can reveal what readers usually miss. Use the page to prepare, then verify the personal medical pieces with a licensed clinician.
Original tools and data
These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.
Editorial refresh
Calibrate vs Found now carries extra 2026 context around semaglutide, tirzepatide, cash-pay pricing, safety signals, calibrate, found, because those are the subtopics readers tend to compare before they trust a medical or wellness recommendation.
Instead of adding filler, this page keeps the named treatment terms, practical verification points, and next-step questions close to calibrate vs found.
Readers should use the section to check current eligibility, pharmacy or provider policies, and safety questions with a licensed professional before acting.
Custom 2026 image for Calibrate vs Found, provider comparisons, and better treatment decision-making.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.
Disclosure: FormBlends is one of the providers discussed in this article. Our editorial team independently researches and verifies all pricing and claims. Pricing was last verified in March 2026. Read our editorial policy.
Written by FormBlends Editorial Research
Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.
Ready to get started?
Provider-reviewed GLP-1 and peptide therapy, delivered to your door.
Start Your ConsultationGet a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.
Compare Calibrate, Found, and Sequence GLP-1 weight loss programs. Pricing, physician oversight, medications, and real patient outcomes analyzed side-by-side.
Provider ComparisonsComplete comparison of 6 major GLP-1 weight loss programs. Compare pricing, medications, doctor access, and patient experience to find the best option.
Provider ComparisonsCalibrate vs Found Weight Loss comparison. Side-by-side review of these GLP-1 weight loss programs.
Provider ComparisonsCompare FormBlends, Calibrate, and Found GLP-1 programs. Detailed analysis of pricing, medications, doctor quality, and support to find your best option.
Provider ComparisonsCompare Hims vs Calibrate for GLP-1 weight loss medications. Pricing, doctor access, and program differences analyzed. Find the right telehealth option for you.
Provider ComparisonsCompare Noom Med ($149), Calibrate ($138), and Sequence ($247) GLP-1 programs. See pricing, medications, doctor access, and coaching to find your best fit.
Provider-informed calculators to support your weight loss journey.
Check your body mass index and see if you may qualify for GLP-1 therapy.
Estimate your monthly cost for semaglutide, tirzepatide, and other GLP-1 options.
Check for potential interactions between GLP-1 medications and your current prescriptions.
Build a personalized titration schedule for your GLP-1 medication.